These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23601492)

  • 21. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination.
    Nochi T; Takagi H; Yuki Y; Yang L; Masumura T; Mejima M; Nakanishi U; Matsumura A; Uozumi A; Hiroi T; Morita S; Tanaka K; Takaiwa F; Kiyono H
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10986-91. PubMed ID: 17573530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a food plant-based oral cholera toxin B subunit vaccine.
    Arakawa T; Chong DK; Langridge WH
    Nat Biotechnol; 1998 Mar; 16(3):292-7. PubMed ID: 9528012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit.
    Guo L; Li X; Tang F; He Y; Xing Y; Deng X; Xi T
    Appl Microbiol Biotechnol; 2012 Mar; 93(5):1937-45. PubMed ID: 22134639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
    Matoba N; Geyer BC; Kilbourne J; Alfsen A; Bomsel M; Mor TS
    Vaccine; 2006 Jun; 24(23):5047-55. PubMed ID: 16621185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicochemically stable cholera toxin B subunit pentamer created by peripheral molecular constraints imposed by de novo-introduced intersubunit disulfide crosslinks.
    Miyata T; Oshiro S; Harakuni T; Taira T; Matsuzaki G; Arakawa T
    Vaccine; 2012 Jun; 30(28):4225-32. PubMed ID: 22542816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the immunogenic potential of plant-expressed cholera toxin B subunit.
    Jani D; Singh NK; Bhattacharya S; Meena LS; Singh Y; Upadhyay SN; Sharma AK; Tyagi AK
    Plant Cell Rep; 2004 Feb; 22(7):471-7. PubMed ID: 14517689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of neutralizing antibodies by a tobacco chloroplast-derived vaccine based on a B cell epitope from canine parvovirus.
    Molina A; Veramendi J; Hervás-Stubbs S
    Virology; 2005 Nov; 342(2):266-75. PubMed ID: 16140352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
    Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T
    Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli.
    Kim TG; Huy NX; Kim MY; Jeong DK; Jang YS; Yang MS; Langridge WH; Lee JY
    Mol Biotechnol; 2009 Feb; 41(2):157-64. PubMed ID: 18807220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and active testing of VP7 from GCRV (Grass carp reovirus) fused with cholera toxin B subunit in rice calli.
    Zhang Q; Xu B; Pan J; Liu D; Lv R; Yan D
    Protein Expr Purif; 2019 Jun; 158():1-8. PubMed ID: 30753891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
    Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
    Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
    Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit.
    Rhie GE; Jung HM; Kim BS; Mekalanos JJ
    Vaccine; 2008 Oct; 26(43):5443-8. PubMed ID: 18582519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholera toxin B subunit-domain III of dengue virus envelope glycoprotein E fusion protein production in transgenic plants.
    Kim TG; Kim MY; Yang MS
    Protein Expr Purif; 2010 Dec; 74(2):236-41. PubMed ID: 20691270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery.
    Davoodi-Semiromi A; Schreiber M; Nalapalli S; Verma D; Singh ND; Banks RK; Chakrabarti D; Daniell H
    Plant Biotechnol J; 2010 Feb; 8(2):223-42. PubMed ID: 20051036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and immunogenicity analysis of a recombinant fusion protein of V. Cholera ctB and H. pylori ure I].
    Wang BN; Yang XF; Shi QF; Li MY; Chen CP; Cao K; Li H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):276-9. PubMed ID: 16643777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (As16) of Ascaris suum fused with cholera toxin B subunit.
    Matsumoto Y; Suzuki S; Nozoye T; Yamakawa T; Takashima Y; Arakawa T; Tsuji N; Takaiwa F; Hayashi Y
    Transgenic Res; 2009 Apr; 18(2):185-92. PubMed ID: 18763047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral immunisation of mice with transgenic rice calli expressing cholera toxin B subunit fused to consensus dengue cEDIII antigen induces antibodies to all four dengue serotypes.
    Kim MY; Kim BY; Oh SM; Reljic R; Jang YS; Yang MS
    Plant Mol Biol; 2016 Oct; 92(3):347-56. PubMed ID: 27566485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.